Skip to main content

Table 4 Summary of statistical analysis of proton pump inhibitor comparison (Study 2)

From: The pharmacokinetics and pharmacodynamics of danirixin (GSK1325756) − a selective CXCR2 antagonist − in healthy adult subjects

 

Danirixin 100 mg Fasted + PPI

Danirixin 100 mg Fasted

Treatment Difference (Fasted + PPI vs. Fasted)

 

n

Adjusted Geometric Mean (SE Logs)

n

Adjusted Geometric Mean (SE Logs)

Estimate

90 % CI

AUC (0-∞)(ng h/mL)

12

6220 (0.1705)

13

14,020 (0.1659)

0.444

(0.337, 0.584)

Cmax(ng/mL)

15

813 (0.1646)

15

2235 (0.1646)

0.364

(0.267, 0.496)